TEL AVIV, ISRAEL — Biotech and food tech start-up SuperMeat raised $3 million in a seed funding round led by venture capital firms.
SuperMeat products are made by growing cells extracted from chickens. The company expects to use the funding to bring its products to market at a price point competitive with conventionally produced chicken cuts.
|Ido Savir, co-founder and c.e.o. of SuperMeat|
“We’re proud that SuperMeat is at the forefront of the rapidly-evolving clean meat industry,” said Ido Savir, co-founder and chief executive officer. “Our team is comprised of a diverse group of top-tier scientists, food engineers and chefs, working together with the best production experts from the pharmaceutical industry to create a new generation of meat products that are sustainable, cost-efficient, animal-friendly, and, of course, delicious.”
In addition to the funding round, SuperMeat announced a partnership with PHW, a leading poultry producer in Rechterfeld, Germany, that markets chicken, turkey and duck products under the Wiesenhof brand. Peter Wesjohann, c.e.o. of PHW-Gruppe, said the company’s equity investment in SuperMeat demonstrates how PHW has “left the beaten path” in conducting business.
|Peter Wesjohann, c.e.o. of PHW-Gruppe|